CureVac’s Covid Vaccine Performed Badly in Trial, In Part Due to Variants

The results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said.

from NYT > Top Stories https://ift.tt/3iRcv0T Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/2KrY6cn https://youtu.be/QFwQ6JvyPa8